EP1711218A2 - Dispositif d'injection a element de dosage enclenchable - Google Patents

Dispositif d'injection a element de dosage enclenchable

Info

Publication number
EP1711218A2
EP1711218A2 EP05700335A EP05700335A EP1711218A2 EP 1711218 A2 EP1711218 A2 EP 1711218A2 EP 05700335 A EP05700335 A EP 05700335A EP 05700335 A EP05700335 A EP 05700335A EP 1711218 A2 EP1711218 A2 EP 1711218A2
Authority
EP
European Patent Office
Prior art keywords
latching
locking
dosing
movement
injection device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05700335A
Other languages
German (de)
English (en)
Inventor
Lorenz Broennimann
Fritz Kirchhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecpharma Licensing AG
Original Assignee
Tecpharma Licensing AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecpharma Licensing AG filed Critical Tecpharma Licensing AG
Publication of EP1711218A2 publication Critical patent/EP1711218A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31525—Dosing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/31555—Mechanically operated dose setting member by purely axial movement of dose setting member, e.g. during setting or filling of a syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A61M5/31578—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod
    • A61M5/3158—Constructional features or modes of drive mechanisms for piston rods based on axial translation, i.e. components directly operatively associated and axially moved with plunger rod performed by axially moving actuator operated by user, e.g. an injection button
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3125—Details specific display means, e.g. to indicate dose setting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3146—Priming, e.g. purging, reducing backlash or clearance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3156—Mechanically operated dose setting member using volume steps only adjustable in discrete intervals, i.e. individually distinct intervals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/3159—Dose expelling manners
    • A61M5/31593—Multi-dose, i.e. individually set dose repeatedly administered from the same medicament reservoir
    • A61M5/31595—Pre-defined multi-dose administration by repeated overcoming of means blocking the free advancing movement of piston rod, e.g. by tearing or de-blocking

Definitions

  • the invention relates to an injection device which has a lockable metering element for the metered administration of an injectable product.
  • the injection device is preferably used for self-administration of the product. It is preferably used to administer a parathyroid hormone, for example heparin, in the treatment of osteoporosis. However, it can also be used in other therapies, for example for the administration of insulin in diabetes therapy.
  • the injection device as a whole has the shape of a pen.
  • Injection pens are widely used, not least because of their convenient shape, especially in the self-administration of medication. Easy handling, exact dosing and safety in dosing with the lowest possible price for the devices are of great importance, especially in self-administration.
  • An injection pen specially developed for osteoporosis therapy is known from WO 02/30495 A2.
  • the drug is delivered from an ampoule using a plunger.
  • the piston is propelled by means of a piston rod which is accommodated in a housing of the pen so as to be axially displaceable.
  • the medication is released through a propulsion stroke, which the piston rod and the piston perform together.
  • the length of the stroke determines the dose administered per delivery.
  • the dose is adjusted using a dosing element that forms a spindle drive with the piston rod.
  • the length of the advance stroke is set by rotating the metering element.
  • the finger To set the dose, the finger must first snap into one of the longest of the V-grooves, so that the dosing element assumes a zero dose position from which it can then perform a first, purely translative backward movement when the finger engages in the V-groove brings the metering member into engagement with a thread formed on the housing. Only engagement with this thread causes the dosing rotary movement of the dosing member to be superimposed on the axial backward movement required for setting the discharge stroke.
  • the dosing mechanism fulfills the demands placed on it from a functional point of view, but is very complex from 1.
  • Another injection pen with a disposable metering member is known from WO 96/07443 AI.
  • the dose is set by means of a dosing rotary movement of the dosing member, which is superimposed on an axial translation movement.
  • the locking mechanism primarily serves to secure the dosing element in the zero dose position.
  • the dosing member is provided on an outer circumferential surface with grooves arranged axially one behind the other. The locking pawl can form the locking engagement with each of these grooves by snapping into the groove in question.
  • the invention relates to an injection device which comprises a housing, a reservoir for a product to be injected, a conveying device and a metering element.
  • the injection device preferably has the shape of a pen.
  • the housing can form the reservoir directly.
  • the housing preferably accommodates a container forming the reservoir, preferably in the form of an ampoule.
  • the product is preferably a medicinal liquid, but can in principle also be an exclusively cosmetically active product.
  • the conveying device acts on the product located in the reservoir and carries out a conveying movement in order to dispense it.
  • the extent of the conveying movement preferably an axial piston stroke, is determined by presetting the metering element.
  • the metering member carries out a propelling movement in a propelling direction and a metering movement against the propelling direction relative to the housing. It is coupled to the conveying device in such a way that the advancing movement effects the conveying movement of the conveying device.
  • the length of a distance determining the dose to be distributed, which the metering element can cover during its advancing movement is set by the metering movement. This corresponds to the presetting mentioned in connection with the conveyor.
  • the coupling of the metering element to the conveying device can advantageously be a simple entrainment intervention with respect to the advance movement, i.e. an intervention which causes the slip-free entrainment of a conveying element of the conveying device, namely a drive or driven element or preferably the conveying device as a whole, when the metering member carries out its propulsive movement.
  • the coupling to the conveying device thus does not have to generate the metering movement of the metering member as a superimposed rotational and translational movement, for example via a spindle drive as in the prior art. Rather, it is sufficient if the metering element is simply decoupled from the conveying device during the execution of its metering movement.
  • the coupling between the metering element and the conveying device can advantageously be formed, for example, as a simple tooth engagement in the manner of a ratchet, as is known from rack pens.
  • the housing forms its locking device for the dosing locking engagement with the dosing member in a housing sleeve section surrounding the dosing member.
  • This locking device is therefore an integral part of the housing and not attached to the outside of the housing, possibly via a joint, such as the housing-side locking device of the injection device of WO 96/07443 AI.
  • the latching device of the housing is referred to below as the first latching device, and that of the dosing member is referred to as the second latching device for distinction.
  • the first latching device is preferably formed directly during the original shaping on the relevant housing sleeve section, ie in one piece with the housing sleeve section.
  • a preferred method of primary shaping is injection molding in plastic.
  • the first latching device is formed separately from the housing sleeve section, but then is not fixed in an articulated manner but rigidly to the housing sleeve section, as a result of which the costs and also the susceptibility to faults are still reduced in comparison with an articulated fastening.
  • the first and the second latching device can each be elastically flexible. However, it is preferred if only one of the two locking devices is resilient and the other is not resilient.
  • the first latching device preferably forms at least one latching surface pointing in the direction of advance in a jacket of the sleeve section.
  • the second latching device engages behind the at least one latching surface of the first latching device in the metering latching engagement.
  • the formation of the at least one latching surface in the jacket of the housing sleeve section is not least advantageous because such a latching surface does not radially take up any additional space beyond the jacket thickness and therefore in turn does not cause the injection device to thicken or promote an advantageously slim shape of the injection device.
  • the at least one latching surface is not formed in the jacket of the housing sleeve section, but projects inwards from an inner jacket surface or outwards from an outer jacket surface, then a latching surface projecting inwardly from the inner jacket surface is preferred to a latching surface projecting outward from the outer jacket surface.
  • the first latching device has a plurality of latching surfaces in order to be able to set different cans, the plurality of latching surfaces are arranged one behind the other at a distance in the direction of advance and are preferably formed like the at least one latching surface mentioned.
  • the at least one latching surface forms a boundary wall of a recess in the casing of the housing sleeve section, particularly preferably a proximal boundary wall.
  • a locking element of the second locking device protrudes into the recess in order to engage behind the at least one locking surface in the dosing locking engagement.
  • the engaging catch element is preferably visible from the outside, so that the dose position of the dosing member can be recognized directly by means of the dosing catch intervention.
  • the housing sleeve section forming the first latching device can be made of a transparent material.
  • a locking element of the second locking device is only visible in the metering locking engagement and is otherwise covered.
  • the mentioned recess is formed in the housing sleeve section as an opening. The opening can be covered from the outside by a window made of transparent material or simply open.
  • the dose positions of the dosing member can advantageously also be read on a dose scale.
  • the dose scale can be attached to the metering element.
  • a dose scale is preferably attached to the housing, particularly preferably directly at the first latching device.
  • Said latching element of the second latching device advantageously also forms the single pointer or possibly one of several pointers of a dose display formed in this way.
  • the second latching device in which the second latching device is elastically flexible for releasing the latching engagement, the second latching device preferably snaps radially outward with respect to a central longitudinal axis of the sleeve section of the housing into the metering latching engagement. In another embodiment, the second latching device snaps into the metering latching engagement in the circumferential direction of the sleeve section of the housing that forms the first latching device.
  • the second locking device is preferably formed in one piece on the dosing member. Forming directly during the primary shaping of the metering element, preferably in plastic injection molding, is particularly preferred.
  • the second latching device is obtained by a separately manufactured latching body being movably supported by the housing, preferably being guided axially, and the separate latching body being movable in and out of the latching engagement relative to the housing and relative to the metering element.
  • a separately manufactured latching body can also be attached to the dosing member or, when the injection device is at least in the assembled state, be firmly connected to the dosing member, the attachment allowing the elastic yielding.
  • the adjustable maximum dose is preferably determined by a fixed end stop, i.e. not determined by the dosing engagement.
  • the specification of the end stop for the maximum dose can, however, also be specified as a detent position in the dosing detent intervention, however this detent intervention should certainly prevent the dosing member from performing a dosing movement beyond the maximum dose position.
  • the fact that the distance that the metering element can take from a starting position to the priming position is significantly shorter than the maximum distance that can be covered up to the maximum dose position means that the maximum distance that can be covered is many times longer than the distance that can be covered into the priming position distance. A multiple in this context does not mean that it must be an integral multiple.
  • the maximum distance that can be covered is typically at least ten times as long as the distance to the priming position.
  • the starting position to which the distance covered can be traced is the zero dose position.
  • the ratios preferably also apply with respect to each further dose position in which the dosing member can lock between the zero dose position and the maximum dose position if different doses can be set by means of a locking action.
  • the latching engagement between the metering member and the housing is preferably formed such that a clear distance remains, measured in the advancing direction, between the at least one latching surface and the engaging latching element, which distance corresponds to the distance covered in the latching engagement for the priming.
  • the clear distance or the distance corresponds to at least one selectable dose unit, preferably a few dose units, for example 2, 3 or 4 dose units.
  • the coupling between the dosing member and the conveying device is formed such that the dosing member executes the dosing movement relative to the conveying device from the zero dose position to the priming position without slippage, by the dosing member and the conveying device in the zero dose -Position and in the priming position are fixed to each other in such a way that a movement of the dosing member in the advancing direction relative to the conveyor is not possible.
  • This requirement is advantageously met by tooth couplings, as are known from rack pens.
  • Another preferred conveying device is known from DE 199 45 397 C2, which is referred to for the coupling of a metering element and a piston rod in that the driver there forms a metering element according to the invention. Coupling with the conveying device thus prevents an undesired movement of the metering member relative to the conveying device from the priming position in the advancing direction, which the metering detent intervention would allow, while on the other hand the latching surface of the housing sleeve section in the priming position acts against the advancing direction for the latching element of the latching element Dosing forms. The elasticity force required to release the dosing latch engagement must reach a size for the fulfillment of the priming position that can be safely felt by the user.
  • the elastic compliance it should also be noted that it can basically be obtained through material elasticity, but that preferably one of the two latching devices or possibly both latching devices is or are form-elastic. Bending elasticity is particularly preferred.
  • the elastic force to be overcome and the shape of the latching element and / or the latching surface forming the stop surface are finely coordinated with one another in combination. Preferred embodiments of the invention are also described in the subclaims and by the combinations of the subclaims.
  • 1 is an injection device according to a first embodiment
  • FIG. 2 shows the injection device of the first exemplary embodiment in a state in which a dosing member of the injection device takes a maximum dose position
  • FIG. 3 shows the injection device of the first exemplary embodiment in a state in which the dosing member takes a priming position
  • FIG. 4 shows the injection device of the first exemplary embodiment in a state in which the dosing member assumes a zero dose position
  • FIG. 5 shows a detent device of the dosing member in detail in the maximum dose position
  • FIG. 8 shows the injection device of the first exemplary embodiment in a plan view of a latching device of a housing of the injection device, the dosing member assuming the maximum dose position, FIG. 9 the top view of FIG. 8, the dosing member assuming the priming position,
  • FIG. 10 shows the top view of FIG. 8, with the dosing member assuming the zero dose position
  • FIG. 11 shows an injection device according to a second exemplary embodiment
  • FIG. 12 shows the injection device of the second exemplary embodiment in a state in which a dosing member of the injection device takes a maximum dose position
  • FIG. 13 shows the injection device of the second exemplary embodiment in a state in which the dosing member takes a priming position
  • FIG. 14 shows the injection device of the second exemplary embodiment in a state in which the dosing member takes a zero dose position
  • FIG. 15 shows a detent device of the dosing member in detail in the maximum dose position
  • FIG. 16 the latching device of the metering element in the priming position
  • FIG. 17 the latching device of the metering element in the zero dose position
  • 18 shows the injection device of the second exemplary embodiment in a plan view of a latching device of a housing of the injection device, the dosing member assuming the maximum dose position
  • FIG. 19 shows the top view of FIG. 18, with the metering element assuming the priming position
  • FIG. 21 shows an injection device according to a third exemplary embodiment
  • FIG. 24 shows the injection device of the third exemplary embodiment in a plan view of a latching device of a housing of the injection device, the dosing member assuming the zero dose position
  • Fig. 25 is the top view of Fig. 24 with the metering member in an intermediate position
  • Fig. 26 is the top view of Fig. 24 with the metering member in the maximum dose position.
  • the injection device is designed as a rack pen and is preferably used to administer a medicament for the treatment of osteoporosis.
  • the dose to be administered per injection is always the same. However, the injection device has a sufficient amount of the product to be able to dispense and administer the same dose several times.
  • the injection device is also equipped with a priming function in order to vent the product-carrying parts of the injection device with as little loss of medication as possible, but safely to be able to.
  • the injection device has a housing 1-3, which is formed in three parts from a distal sleeve section 1, a middle sleeve section 2 and a proximal sleeve section 3, each of which is concentric with the common central longitudinal axis C.
  • a reservoir 4 in the form of an ampoule is accommodated in the distal sleeve section 1.
  • a piston 5 closes the reservoir 4 in a liquid-tight manner at its distal end.
  • the piston 5 is axially movable in the reservoir 4 in a direction of advance V along the longitudinal axis C. accepted.
  • the reservoir 4 At its proximal end, the reservoir 4 has an outlet 6, which is closed by a sealing element.
  • An injection cannula 7 extends through the sealing element.
  • the injection cannula 7 is attached to a lenu age canoe, which is attached to the distal end of the sleeve section 1.
  • a proximal section of the injection cannula 7 pierces the sealing element at the reservoir outlet 6.
  • a first protective cap is placed on the cannula holder, which protects the injection cannula 7 from puncture injuries when it is placed on it.
  • an outer protective cap is placed on the sleeve section 1 and, after removal of the first protective cap, also protects against puncture injuries caused by the cannula section of the injection cannula 7 projecting freely after the first protective cap has been removed.
  • the piston 5 is connected to a piston rod 10 which projects axially from the proximal end of the piston 5 in the proximal direction.
  • the piston rod 10 only presses loosely in the direction of advance V against the piston 5 in order to move it in the reservoir 4 in the direction of advance V. There is no fixed connection. However, it would also be possible for the piston 5 and the piston rod 10 to be firmly connected to one another.
  • the piston 5 and the piston rod 10 form a conveyor with the piston 5 as the output member and the piston rod 10 as the drive member.
  • the piston rod 10 is a rack with at least one, preferably several rows of teeth. In the exemplary embodiment, it has two diametrically opposed, axially extending rows of teeth 11.
  • At least one axially extending engagement device for example a flattening, which serves to guide the piston rod 10 in a straight line in the direction of advance V.
  • the engagement device serving for straight guidance extends at least over such an axial length of the piston rod 10 that the piston rod 10 is guided axially straight over its entire translation path.
  • the piston rod 10 has a flattening over the axial length of the two rows of teeth 1 1 on both longitudinal sides between the rows of teeth 11.
  • the piston rod 10 is supported by the housing 1-3 so that it can only be moved in the direction of advance V relative to the housing 1-3.
  • the engagement means required for this is formed by the middle housing section 2 in the form of two blocking elements 8.
  • One of the blocking elements 8 engages in one of the rows 11 of teeth.
  • the teeth of the rows of teeth 11 are shaped asymmetrically with respect to the direction of advance V such that the locking engagement between the two blocking elements 8 and the rows of teeth 11 allows the piston rod 10 to move in the direction of advance V, but prevents it from the direction of advance V. changed.
  • the rows of teeth 11 are formed as rows of saw teeth with a corresponding alignment of the saw teeth.
  • a dosing member protrudes from the housing 1-3.
  • the metering element is in two parts and consists of a driver 12 and a metering button 20.
  • the driver 12 and the metering button 20 are connected to one another in such a way that they cannot, in particular, make any movements in or against the direction of advance V. They are both concentric to the longitudinal axis C.
  • the dosing button 20 is plugged onto the proximal end of the driver 12 and positively connected to the driver 12 in such a way that said axial relative movement cannot take place and, moreover, no rotary movement about the longitudinal axis C between the driver 12 and the dosing button 20.
  • the driver 12 and the dosing button 20 thus form the physically and functionally uniform dosing member 12/20.
  • the middle housing section 2 guides the metering element 12/20 axially linearly by means of a sliding guide.
  • the metering member 12/20 is coupled to the conveying device 5/10 by tooth engagement, in that the driver 12 engages in the tooth rows 11.
  • the tooth engagement is the same as the tooth engagement of the blocking elements 8.
  • the driver 12 forms two driver elements 13, which protrude like fingers at the distal end in the direction of advance, engage in the rows of teeth 11 and, like the rest, also the blocking elements 8, are elastically bendable radially outward from the engagement.
  • the tooth engagement is formed in such a way that the metering member 12/20 cannot be moved in the forward direction V relative to the piston rod 10, but on the other hand can be moved relative to the piston rod 10 against the forward direction V due to the elastic flexibility of the driver elements 13.
  • the driver elements 13 slide over the rows of teeth 11.
  • the movement of the metering element 12/20 against the direction of advance V sets the medication dose, which during a subsequent advance movement, which the metering element 12/20 together with the conveying device 5 / 10 executes, is distributed.
  • the metering element 12/20 In the starting position of the metering element 12/20 shown in FIG. 1, the metering element 12/20 assumes a zero dose position relative to the housing 1/3, ie a foremost position in the direction of advance V, in which it has a stop face pointing in the direction of advance V. 14 in contact with a counter stop surface 9 pointing against the direction of advance V. is a pouring stop formed by the middle housing section 2. From this zero dose position, the dose to be administered with the next injection is set.
  • the dosing member 12/20 In the maximum dose position, the dosing member 12/20 is in abutment contact with a stop surface 15 formed by the driver 12 and pointing against the direction of advance V against a counter-stop surface 16 facing the direction of advance V, which the proximal sleeve section 3 forms on a front end face.
  • the maximum distance of the dosing movement i.e. the distance from the zero dose position to the maximum dose position is denoted by L. Accordingly, the maximum discharge stroke that can be carried out for the product distribution during the injection has the length L.
  • the metering movement and also the dispensing movement of the metering member 12/20 are thus each predetermined by a hard stop formed by the housing 1-3, on the one hand the stop surface 9 and on the other hand the stop surface 16.
  • the dosing member 12/20 In the zero dose position, the dosing member 12/20 is in a latching engagement with the housing 1-3, in the exemplary embodiment with the proximal sleeve section 3.
  • a defined priming is made possible by the locking intervention.
  • a priming position is defined between the zero dose position and the maximum dose position, into which the dosing member 12/20 can execute a short dosing movement.
  • the locking engagement forms a dosing locking engagement in the simple design of the injection device of the first exemplary embodiment.
  • the priming position is defined by an increase in the force which has to be applied during the metering movement if the metering member 12/20 is to be moved relative to the conveying device 5/10 beyond the priming position into the maximum dose position. Within the distance covered from the zero dose position until the priming position is reached, the force to be applied by the elastic restoring force from the engagement of the driver 12 into the tooth rows 11 of the piston rod 10.
  • the dosing member 12/20 comes into abutment contact against a locking surface of the sleeve section 3 pointing in the direction of advance V.
  • the locking surface is an integral part of the Sleeve section 3, in that the sleeve section 3 forms the locking surface in its sleeve shell.
  • the latching surface is the proximal boundary wall of a recess 17 which breaks through the sleeve section 3 radially to the longitudinal axis C. The latching surface of the recess 17 faces the longitudinal axis C radially.
  • the sleeve section 3 axially guides the driver 12 in a distal section and the metering button 20 in a proximal section, and thereby the metering member 12/20 overall.
  • the sleeve section 3 in its two sections guiding the metering member 12/20 each has a smooth inner surface, which is preferably circular cylindrical in both sections, possibly with the exception of a straight guide for the metering member 12/20.
  • the sleeve section 3 closely surrounds the dosing button 20 over its entire circumference, which does not protrude from the housing 1-3, so that the thickness of the sleeve section 3 measured radially to the longitudinal axis L can be kept small.
  • the recess 17 forms a first locking device.
  • a second latching device which forms the latching engagement with it is formed on the dosing button 20 of the metering member 12/20 and comprises a latching element 21 which projects into the recess 17 in the latching engagement.
  • the latching element 21 is a cam which projects radially outward from an elastic bending tongue.
  • the locking element 21 and the bending tongue form the second locking device.
  • Fig. 2 shows the injection device in a state in which the dosing member 12/20 occupies the maximum dose position. The proximal part of the injection device is shown. The locking engagement is released in the maximum dose position. The locking element 12 presses against the smooth inner surface of the sleeve section 3.
  • the locking element 21 and a section of the surrounding sleeve section 3 are again shown in an enlarged view in FIG. 5 in the maximum dose position.
  • the bending tongue carrying the latching element 21 is provided with the reference symbol 22. It protrudes from one the forward direction of the end face of the dosing button 20 in the forwarding direction V and carries the forwarding direction V from the end face of the dosing button 20 at a distance from the locking element 21.
  • the bending tongue 22 In the maximum dose position, the bending tongue 22 is elastically bent radially inward relative to its relieved state, so that Latching element 21 presses with the elastic bending force of the bending tongue 22 against the inner surface of the sleeve section 3.
  • FIG 3 shows the injection device in a state in which the dosing member 12/20 is in the priming position.
  • the locking engagement in the priming position can be seen particularly well in the enlargement of FIG. 6.
  • the locking element 21 is in the locking position with the locking surface formed by the recess in a stop contact.
  • the latching surface of the recess 17 is provided with the reference symbol 17a in FIG. 6. While the latching surface 17a is radially straight, the latching element 21 tapers in the form of a counter surface 21a towards its free, radially outer end.
  • the counter surface 21 a is a straight, inclined surface on the locking element 21 which is inclined to the radial. An outwardly bulging shape of the locking element would also be possible, for example, to form the counter surface.
  • a bevel or curvature in the latching element 21 one can also be formed on the latching surface 17a.
  • Fig. 4 shows the injection device in a state in which the dosing member 12/20 assumes the zero dose position.
  • FIG. 7 shows the region of the locking engagement for the zero dose position enlarged.
  • the locking element 21 protrudes freely into the recess 17, ie the bending tongue 22 is relieved.
  • the detent element 21 is at a clearance p measured in the advancing direction V from the detent surface 17a.
  • the metering member 12/20 can be moved against the direction of advance V within the recess 17 with the relief tongue 22 relieved against the latching surface 17a. This short part of the metering movement is predetermined by the engagement of the drivers 13 in the tooth rows 11 of the piston rod 10.
  • the clear distance p can in particular be dimensioned such that the dosing member 12/20 from the zero dose position along a few tooth gaps along the rows of teeth 11 the piston rod 10 can be moved, for example by 2, 3 or 4 tooth gaps, the distance between two consecutive tooth gaps corresponding to one dose if the two rows of teeth 11 each have their tooth gaps at the same axial height.
  • the metering can be refined again in a manner known per se by an axial displacement of the rows of teeth 11 and possibly by additional axially offset rows of teeth.
  • FIGS. 8, 9 and 10 each show the injection device in the same view from the outside of the recess 17.
  • the state shown in FIG. 8 corresponds to that of FIGS. 2 and 5, i.e. the dosing member 12/20 takes the maximum dose position.
  • Fig. 9 it takes the priming position and in Fig. 10 the zero dose position.
  • the locking element 21 is visible from the outside through the recess 17.
  • the maximum dose position it is covered by the jacket of the sleeve section 3. In this way, an optical display of the dose position is also obtained at the same time.
  • a particular advantage of this dose display is that the locking element 21 determining the priming position itself forms part of the display.
  • the latching element 21 is provided with a marking, preferably a special color marking, on its end pointing radially outward and visible through the cutout 17 to improve identification by sight, which is different from the sleeve section 3 and the stands out clearly through the recess 17 also recognizable background.
  • the first injection can be carried out as follows after the cannula holder holding the injection cannula 7 has been put on:
  • the injection device is in the state shown in FIG. 1.
  • the dosing member 12/20 assumes the zero dose position.
  • Priming is carried out before the first injection.
  • the dosing member 12/20 is gripped on the dosing button 20 protruding from the housing 1-3 and pulled back relative to the housing 1-3 and the conveyor 5/10 to the priming position shown in FIGS. 3 and 6.
  • This increase in force is due to the fact that the latching element 21 is in stop contact in the priming position. reaches the locking surface 17a and further retraction of the metering member 12/20 is only possible against the elastic force of the bending tongue 22.
  • the counter surface 21a of the locking element 21 facing the locking surface 17a is shaped in such a way that self-locking is reliably avoided on the one hand, but on the other hand the increase in force required to overcome the resistance does not take place gradually but suddenly.
  • the shape of the locking element 21 and the elastic force generated by the bending tongue 22 are matched to one another accordingly.
  • the injection cannula 7 is exposed by removing the two protective caps.
  • the metering element 12/20 is then moved in the forward direction V by manual pressure on the metering button 20.
  • the metering member 12/20 takes the conveying device 5/10 ' with it due to the tooth engagement of the driver 12 in the tooth rows 11, and product and possibly air present in the reservoir 4 are displaced from the reservoir 4.
  • the priming stroke carried out in the context of this dispensing movement corresponds to the clear distance p that the latching element 21 has in the zero dose position from the latching surface 17a of the sleeve section 3.
  • the clear distance p ie the priming stroke, is dimensioned such that any residual air is safely removed from the reservoir 4, but on the other hand as little medication as possible is lost.
  • Liquid outlet at the outlet of the injection cannula 7 signals that the product-carrying parts of the injection device from the reservoir 4 to the outlet of the injection cannula 7 are vented inclusive. At the same time, this visual inspection offers a certain guarantee for the proper functioning of the injection device.
  • the injection device should be held so that the injection needle 7 points upwards.
  • the injection device is ready to set and administer a dose. In particular, the metering element 12/20 assumes its zero dose position after the priming stroke has been carried out.
  • the user pulls the dosing member 12/20 again at the dosing button 20 against the direction of advance V, but this time until the fixed end stop 16 is reached, so that the dosing member 12/20 assumes the maximum dose position.
  • the dosing movement is a linear movement against the advance direction V.
  • the injection cannula 7 is inserted through the skin into subcutaneous tissue.
  • the metering member 12/20 is pressed in the direction of advance V into the housing 1-3 up to the stop surface 9 of the discharge stop. This corresponds to the maximum discharge stroke L.
  • the dosing member 12/20 again takes the conveying device 5/10 with it in the direction of advance V, and the dose corresponding to the maximum discharge stroke L is poured out and administered.
  • the latching surface 17a blocks the latching element, which is modified for this in that it does not have the inclined surface 21a, but is instead provided with a surface which is at least substantially perpendicular to the retraction direction. This prevents elastic yielding solely on the basis of a retraction force acting in the retraction direction.
  • the modified locking element rather forms a fixed stop in the priming position, as a result of which maximum security is obtained that actually no more than the desired priming dose is set.
  • the modified latching element is also elastically flexible and can be moved from the outside by actuation from the stop with the latching surface 17a, preferably by being pressed in.
  • 11 to 20 show an injection device according to a second embodiment, which differs from the injection device of the first embodiment with respect to the first latching device formed by the sleeve section 3.
  • the sleeve section 3 does not differ from the sleeve section 3 of the injection device of the first exemplary embodiment. Only the differences are described below, while reference is made to the explanations for the first exemplary embodiment with regard to the similarities.
  • the first latching device comprises a plurality of cutouts in the jacket of the sleeve section 3, so that different doses can be set by the metering latching engagement of the metering member 12/20 with the sleeve section 3 and administered with the injection device.
  • the first latching device formed by the sleeve section 3 is formed by the same recess 17 as in the first exemplary embodiment and additional recesses 18 in the jacket of the sleeve section 3.
  • the recess 17 is the foremost in the direction of advance V, i.e. Most distal of the recesses 17 and 18.
  • the recesses 17 and 18 are formed in the advancing direction V in line with one another and spaced apart from one another in the jacket of the sleeve section 3 as openings.
  • the recesses 18 and the latching surface 18a formed by each of these recesses 18 are identical.
  • the cutouts 18 differ from the cutout 17 only in that the cutouts 18 have no priming function and are accordingly axially shorter than the cutout 17 by the clear priming distance p. Furthermore, the maximum dose position shown in FIGS. 12 and 15, a recess 18 is provided, into which the latching element 21 engages in the maximum dose position, in order to convey the same “adjustment feeling” to the user for each of the discretely adjustable doses.
  • the injection device of the second exemplary embodiment has the only further difference from the first embodiment. example on a dose scale.
  • the dose scale is attached to the sleeve section 3 in a clearly legible manner directly at the cutouts 17 and 18.
  • 18 to 20 each show a view of the recesses 17 and 18 and the dose scale.
  • 18 shows the dosing member 12/20 in the maximum dose position corresponding to FIGS. 12 and 15.
  • FIG. 19 shows the injection device in an intermediate dose position of the dosing member 12/20.
  • Each latching intervention in one of the recesses 18 in front of the most proximal recess 18 is understood as an intermediate dose position.
  • the metering element 12/20 assumes an intermediate dose position in which it engages in the recess 18 that follows the recess 17.
  • the dose scale for this intermediate dose position marks 20 dose units.
  • 20 shows the injection device in the zero dose position of the dosing member 12/20, which it also occupies in FIGS. 11, 14 and 17.
  • the dose scale marks the zero dose position by the number 0.
  • the priming position is marked on the latching surface 17a of the recess 17 with the number 4, the marking line of which is flush with the latching surface 17a, while the marking line starting from the 0 by the priming distance p from the Rest area 17a is removed.
  • the injection device of the first exemplary embodiment could also have an analogously formed dose scale, although its dose scale would only include the dose numbers for the zero dose position and the priming position. Instead of a number, the letter P (for priming) could be used for the priming position in both the first and the second exemplary embodiment.
  • the latching element 21 of the second exemplary embodiment is also provided on its side pointing in the direction of advance V with a further inclined surface 21b. While the inclined surface 21b has no function in the latching element of the first exemplary embodiment, in the second exemplary embodiment it facilitates the propulsion of the metering element 12/20 when it is poured out by preventing blocking.
  • inclined surfaces could be provided in the respective end walls of the cutouts 17 and / or 18 which are relevant to the map. Instead of being flat, the inclined surface 21b could also be curved, preferably curved outwards. The same applies to sliding surfaces that can be formed in the recesses 18.
  • 21 to 26 show an injection device according to a third embodiment, which differs from the other two exemplary embodiments both with regard to the first latching device and with respect to the second latching device and also with respect to the latching engagement as such.
  • the injection device again corresponds to the injection devices of the other two exemplary embodiments, so that reference is made to the statements relating to the first exemplary embodiment in this regard.
  • a difference to the other two exemplary embodiments is that the locking engagement is not produced by a radial snap movement, but by a snap movement of the second locking device directed in the circumferential direction of the sleeve section 3 and is released by a corresponding counter movement.
  • the metering button 20 does not form the second locking device in one piece.
  • the second locking device is formed by means of a separate dosing locking body which is inserted between the sleeve section 3 and the driver 12 in a recess formed by the sleeve section 3. From the one-piece dosing locking body, the locking body parts 25, 26 and 27 can be seen in the longitudinal section of FIG. 21.
  • FIGS. 24 to 26 also show a locking element 24 projecting from the locking body part 25 in the circumferential direction of the sleeve section 3.
  • FIGS. 22 and 23 also show the two cross sections A-A and B-B identified in FIG. 21.
  • FIGS. 21 to 26 in summary.
  • the dosing detent body has a straight fastening part 27 which extends axially in the assembled state, a connecting part 26 which projects radially outwards at a proximal end, a holding part 25 which projects axially in the proximal direction from the connecting part 26 and which is formed in the manner of a cam, of which Holding part 26 in the circumferential direction of the sleeve section 3 protruding locking element 24.
  • the sleeve section 3 has an axially extending recess 28 in a distal jacket region that closely surrounds the driver 12 on the jacket inner surface, in which the connecting part 27 of the latching body 24-27 is axially straight , In a proximal end section, the recess 28 widens in the circumferential direction of the sleeve section 3.
  • the connecting part 27 continues to be straight on a first of its two circumferential sides in the end section. On the other, second circumferential side of the connecting part 27, a space remains in the end section of the recess 28 that is elastic Bending of the connecting part 27 in the circumferential direction allows.
  • the holding part 25 of the latching body 24-27 protrudes outward beyond the sleeve section 3 of the housing 1-3, so that the latching body 24-27 is actuated to release the metering latching engagement, namely can be bent elastically in the circumferential direction from the latching engagement.
  • the areas of the tines pointing in the direction of advance V form the latching areas 19a and the areas facing the direction of advance V form latching areas 19b of this first latching device. Between the tines there are markings on a dose scale and a dose number in the middle of the valleys.
  • 21 and 24 show the metering member 12/20 in the zero dose position. In this position, the locking element 24 engages in the most distal bottom of the comb. 26 shows the dosing member 12/20 in the maximum dose position in which the latching element 24 engages in the most proximal base of the comb.
  • FIG. 25 shows the injection device in the same view as FIGS. 24 and 26, but during the dosing movement of the latching body 24-27 from the zero dose position into the maximum dose position.
  • the front and the rear of the locking element 24 and also the locking surfaces 19a and 19b formed by the comb teeth are shaped such that a dosing movement of the dosing member 12/20 is only possible by actuating the locking body 24-27.
  • the axial position of the locking body 24-27 determines the dose.
  • the locking body 24-27 is bent in the circumferential direction of the sleeve clamp 3 against its elastic restoring force from the locking engagement and moved axially into the desired locking position.
  • the latching body forms a metering stop for the metering member 12/20 in the selected axial latching position because of the latching engagement in which the latching body 24-27 is axially fixed to the sleeve section 3 when it performs its metering movement directed against the direction of advance V.
  • a distal end face of the locking body 24-27 acts as a dosing stop and a cam 14a of the dosing member 12/20 projecting transversely to the direction of advance V acts as a pair of stops.
  • the discharge movement of the metering member 12/20 is limited by a discharge stop 9, as in the other exemplary embodiments.
  • the rasp body 24-27 is set in its most distal locking position.
  • the dosing member 12/20 is moved away from the pouring stop 9 against the advancing direction V to the dosing stop of the latching body 24-27 and can then be moved by the dosing stop by the short priming stroke up to the pouring stop 9.
  • a dose scale is plotted along the first locking device, which ranges from a minimum dose "P" to a maximum dose (FIGS. 24-26). The minimum dose corresponds to the priming dose.
  • the axial distance between the discharge stop 9 and the most distal locking position of the second locking device is selected accordingly.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un dispositif d'injection comprenant: a) un boîtier (1-3); b) un réservoir (4) formé par le boîtier (1-3) ou logé dans ce dernier pour un produit à injecter; c) un dispositif de transport (5/10) exécutant un mouvement de refoulement pour refouler une dose de produit déterminée hors du réservoir (4); d) un élément de dosage (12/20) qui, relativement au boîtier (1-3), effectue un mouvement de poussée dans un sens de poussée (V) et un mouvement de dosage dans le sens opposé au sens de poussée (V), cet élément de dosage étant couplé au dispositif de transport (5/10) de sorte que le mouvement de poussée provoque le mouvement de refoulement du dispositif de transport (5/10), le mouvement de dosage réglant la longueur (L) d'une distance déterminant la dose extraite, cette distance étant parcourue par l'élément de dosage (12/20) lors du mouvement de poussée; e) un premier dispositif d'enclenchement (17; 17, 18; 19) que forme le boîtier (1-3) dans une partie de gaine (3) entourant l'élément de dosage (12/20); f) un deuxième dispositif d'enclenchement (21, 22; 24-28) formé par l'élément de dosage (12/20) ou par un dispositif de dosage encliquetable (24-27) supplémentaire séparé; g) un engrènement des dispositifs d'enclenchement pouvant être libéré par un mouvement de dosage sans rotation de l'élément de dosage (12/20) ou du dispositif de dosage encliquetable (24-27) supplémentaire séparé.
EP05700335A 2004-01-28 2005-01-26 Dispositif d'injection a element de dosage enclenchable Withdrawn EP1711218A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004004310A DE102004004310A1 (de) 2004-01-28 2004-01-28 Injektionsgerät mit verrastbarem Dosierglied
PCT/CH2005/000040 WO2005072796A2 (fr) 2004-01-28 2005-01-26 Dispositif d'injection a element de dosage enclenchable

Publications (1)

Publication Number Publication Date
EP1711218A2 true EP1711218A2 (fr) 2006-10-18

Family

ID=34801148

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05700335A Withdrawn EP1711218A2 (fr) 2004-01-28 2005-01-26 Dispositif d'injection a element de dosage enclenchable

Country Status (7)

Country Link
US (1) US7169133B2 (fr)
EP (1) EP1711218A2 (fr)
JP (1) JP4405969B2 (fr)
CN (1) CN1913932B (fr)
AU (1) AU2005209023B2 (fr)
DE (1) DE102004004310A1 (fr)
WO (1) WO2005072796A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068290A2 (fr) 2002-02-11 2003-08-21 Antares Pharma, Inc. Injecteur intradermique
DE102004041151A1 (de) * 2004-08-25 2006-03-02 Tecpharma Licensing Ag Dosiervorrichtung mit Ablaufsteuerung
DE102005023824A1 (de) * 2005-05-24 2006-12-07 Tecpharma Licensing Ag Dosiervorrichtung für eine Injektionsvorrichtung
DE102006004562A1 (de) 2006-01-17 2007-07-19 Tecpharma Licensing Ag Vorschubstange mit Koppelelement
DE102006004561A1 (de) * 2006-01-17 2007-07-26 Tecpharma Licensing Ag Injektionsvorrichtung mit gesichertem Drehknopf
DE102006004563A1 (de) 2006-01-17 2007-07-19 Tecpharma Licensing Ag Ausfahrbarer Dosierknopf
DE102006006796A1 (de) * 2006-02-14 2007-08-16 Tecpharma Licensing Ag Überlappende Anzeige
EP2019701B1 (fr) 2006-05-16 2010-02-24 Novo Nordisk A/S Mécanisme d'engrenage pour dispositif d'injection
JP4131001B2 (ja) * 2006-07-28 2008-08-13 大成化工株式会社 定量吐出装置
DE102006038101A1 (de) 2006-08-14 2008-02-21 Tecpharma Licensing Ag Injektionsvorrichtung mit Klauensicherung
DE102006038123C5 (de) 2006-08-14 2012-05-03 Tecpharma Licensing Ag Injektionsvorrichtung mit Mechanikverriegelung
DE102007001432A1 (de) 2006-08-14 2008-02-21 Tecpharma Licensing Ag Dosiermechaniksperrung
DE102006038103B4 (de) 2006-08-14 2017-02-23 Tecpharma Licensing Ag Injektionsvorrichtung mit variabler Gewindeführung
DE102007018696A1 (de) * 2007-04-18 2008-10-23 Sanofi-Aventis Deutschland Gmbh Injektionsvorrichtung zur Abgabe eines Medikaments
ES2738539T3 (es) * 2008-08-05 2020-01-23 Antares Pharma Inc Inyector de dosis múltiples
CN102186517B (zh) * 2008-09-18 2013-07-24 贝克顿·迪金森公司 具有带棘齿的柱塞的医用注射器
US9238106B2 (en) 2009-06-01 2016-01-19 Sanofi-Aventis Deutschland Gmbh Dose setting mechanism for priming a drug delivery device
GB201301046D0 (en) 2013-01-21 2013-03-06 Owen Mumford Ltd Dosing mechanism
DE202013001350U1 (de) * 2013-02-08 2014-05-09 Haselmeier Gmbh Injektionsgerät
JP6412939B2 (ja) * 2013-08-06 2018-10-24 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 薬物送達デバイス
WO2015026737A1 (fr) 2013-08-19 2015-02-26 Dr. Reddy's Laboratories, Ltd. Auto-injecteur à dose unique sélectionnable et procédés de fabrication et d'utilisation associés
PL229073B1 (pl) * 2016-02-19 2018-06-29 Copernicus Spolka Z Ograniczona Odpowiedzialnoscia Mechanizm wskaźnikowy urządzenia do wstrzykiwania substancji farmaceutycznej i urządzenie do wstrzykiwania zawierające taki mechanizm wskaźnikowy
EP3621677B1 (fr) * 2017-05-09 2023-05-31 SHL Medical AG Ensemble verrou de transport et dispositif d'administration de médicament comprenant l'ensemble verrou de transport
US11338092B1 (en) 2017-07-03 2022-05-24 Rundeep Gadh Electronically regulated injection pen
US10688247B2 (en) * 2017-07-13 2020-06-23 Haselmeier Ag Injection device with flexible dose selection
CN111491680B (zh) 2017-12-13 2023-08-29 里珍纳龙药品有限公司 用于精确剂量输送的装置和方法
US11969583B2 (en) 2018-07-17 2024-04-30 Medmix Switzerland Ag Injection device with dose interruption fail safe
JP2022535558A (ja) 2019-06-05 2022-08-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 正確な容量送達のための装置
WO2023117788A1 (fr) * 2021-12-22 2023-06-29 Shl Medical Ag Instructions de livraison de médicaments par communication visuelle

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084017A (en) * 1989-10-10 1992-01-28 John Maffetone Self disabling, single use, hypodermic syringe
FR2701211B1 (fr) * 1993-02-08 1995-05-24 Aguettant Lab Instrument doseur, notamment d'injection
GB9316692D0 (en) * 1993-08-11 1993-09-29 Smithkline Beecham Plc Novel device
US5514097A (en) * 1994-02-14 1996-05-07 Genentech, Inc. Self administered injection pen apparatus and method
JP3741730B2 (ja) * 1996-04-02 2006-02-01 テクファーマ・ライセンシング・アクチェンゲゼルシャフト 注射装置
US6319234B1 (en) * 1997-02-12 2001-11-20 Sergio Restelli Disposable safety syringe
DE19945397C2 (de) * 1999-09-22 2001-07-19 Disetronic Licensing Ag Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
DE10047637A1 (de) * 2000-09-26 2002-04-25 Disetronic Licensing Ag Vorrichtung zur Verabreichung eines injizierbaren Produkts
ATE289834T1 (de) * 2001-07-16 2005-03-15 Lilly Co Eli Medikamentenverabreichungsvorrichtung mit durch rotation ausführbarem priming und durch zug- /schubbewegung ausführbarer injektion
DE10232411A1 (de) * 2002-07-17 2004-02-05 Disetronic Licensing Ag Verabreichungsgerät mit verstellbarem Dosieranschlag
DE10351597A1 (de) * 2003-11-05 2005-06-16 Tecpharma Licensing Ag Vorrichtung für die Verabreichung eines injizierbaren Produkts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005072796A3 *

Also Published As

Publication number Publication date
DE102004004310A1 (de) 2005-08-18
US7169133B2 (en) 2007-01-30
CN1913932B (zh) 2010-05-05
US20050177115A1 (en) 2005-08-11
CN1913932A (zh) 2007-02-14
AU2005209023A1 (en) 2005-08-11
JP4405969B2 (ja) 2010-01-27
WO2005072796A2 (fr) 2005-08-11
WO2005072796A3 (fr) 2005-11-10
AU2005209023B2 (en) 2009-11-05
JP2008506418A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
EP1711218A2 (fr) Dispositif d'injection a element de dosage enclenchable
DE10106367B4 (de) Ablesehilfe für eine Vorrichtung zur Verabreichung einer einstellbaren Dosis eines injizierbaren Produkts
DE60308042T2 (de) Stiftförmige medikamentenspritze
EP2515973B1 (fr) Dispositif d'injection comportant une gaine de protection d'aiguille
EP0268191B1 (fr) Dispositif d'injection
EP1414505B1 (fr) Appareil d'administration comportant un dispositif de dosage
EP1684831B1 (fr) Dispositif pour administrer un produit a injecter
EP2445552B1 (fr) Appareil d administration à fonction d amorçage
DE10163325B4 (de) Verriegelungssperre für eine Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts
DE10232410B4 (de) Verabreichungsgerät mit Dosisanzeige
EP1414506A2 (fr) Module de reservoir muni d'une tige de piston
EP1642094A2 (fr) Dispositif d'administration d'un produit liquide
DE10163328A1 (de) Verabreichungsgerät mit Verdrehsicherung
DE8509572U1 (de) Abgabevorrichtung, insbesondere medizinische Spritze, zur Abgabe vorbestimmter, aufeinander folgender Menge einer Medizin
EP1742689A1 (fr) Dispositif pour administrer un produit injectable, a dispositif de dosage securise
DE10163329A1 (de) Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts für eine dosierte Verabreichung eines ausschüttbaren Produkts
WO2016033701A1 (fr) Dispositif d'injection comprenant une commande de déroulement mécanique
DD299156A5 (de) Vorrichtung zur abgabe von mehrfachen kontrollierten dosen
WO2004006997A1 (fr) Dispositif d'administration presentant une tige de piston a retour bloque
DE10106368B4 (de) Verstellsperre für eine Vorrichtung zur Verabreichung einer einstellbaren Dosis eines injizierbaren Produkts
WO2011029468A1 (fr) Dispositif d'administration d'un produit injectable, présentant un compteur de déversements

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060828

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20101103